Utilization of oncoprotein-pulsed dendritic cells as tumor vaccines.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378050%3A_____%2F01%3A23010307" target="_blank" >RIV/68378050:_____/01:23010307 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Utilization of oncoprotein-pulsed dendritic cells as tumor vaccines.
Original language description
Dendritic cells are the most potent professional antigen-presenting cells. This capability makes them attractive vehicles for the delivery of therapeutic cancer vaccines. The lack of tumor antigen presentation on mature DCs in vivo can be bypassed by direct loading of DCs with oncoproteins in vitro. Several aspects of utilization of oncoprotein-pulsed DCs as tumor vaccines are discussed.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EB - Genetics and molecular biology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2001
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Cancer Research and Clinical Oncology
ISSN
0171-5216
e-ISSN
—
Volume of the periodical
127
Issue of the periodical within the volume
8
Country of publishing house
DE - GERMANY
Number of pages
4
Pages from-to
463-466
UT code for WoS article
—
EID of the result in the Scopus database
—